PFE

Building A Dividend Growth Portfolio from Scratch in Today’s Expensive Market

2021-03-17

Research Articles

Introduction Building A Dividend Growth Portfolio Before we talk about a dividend growth portfolio, the stock market as measured by the S&P 500 is at an all-time high. However, that is not what concerns me. What I am worried about is the extremely high relative valuation of the market. To be clear, the market can […]

The Dow Jones – How Bad Is It?

2020-03-17

Research Articles

Introduction The Dow Jones Industrial Average is an index of 30 stocks that is often utilized as a proxy for the overall market. Since it is such a small index, I thought you all might find it interesting to see what the market looks like considering the recent volatility. Therefore, with this video I will […]

Is the New Pfizer an Attractive Investment?

2020-02-25

Research Articles

Introduction Pharmaceutical giant Pfizer (PFE) is a company in transition that will soon be smaller but hopefully more profitable.  Since many of their established drugs are coming off patent, the company is divesting its older drug platform under the Upjohn brand and selling it to Mylan a leading generic pharmaceutical company.  Pfizer believes that this […]

10 More of 50 Fairly-Valued Dividend Growth Stocks Offering Moderately High Yields: Part 2

2018-04-10

Research Articles

Introduction This is the second of a five-part series presenting 50 dividend growth stocks that I have screened for current fair value.  With this article I will be covering 10 additional dividend growth research candidates in addition to the initial 10 that I presented in part 1 found here. Furthermore, I wanted to be clear […]

Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5

2017-10-19

Research Articles

Introduction Thus far, with the first 3 parts of this five-part series, we’ve examined 60% (18 of 30) of the 30 stocks in the Dow Jones Industrial Average.  What we found so far were that the majority of these constituents are currently overvalued or at least fully valued.  Finally, with this Part 4, we will […]

Pfizer Inc. Invest For Attractive Valuation and The 4% Dividend Yield

2017-02-22

Research Articles

Investment Thesis Pfizer Inc (PFE) is one of the world’s largest pharmaceutical firms with sales exceeding $50 billion.  The company is currently attractively valued at a blended P/E ratio of 13.3, offering a current dividend yield of 4%.  Pfizer is awarded an S&P credit rating of AA and possesses a modest debt to capital ratio […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.